Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Squaric acid dibutyl ester - Squarex

Next Previous
X
Search
Drug Profile

Squaric acid dibutyl ester - Squarex

Alternative Names: Quadratic-acid-dibutylester; SADBE; Squaric-Acid-Dibutyl-Ester-solution; Squaric-Acid-solution; SQX 770

Latest Information Update: 07 Dec 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Squarex
  • Class Antivirals; Esters; Immunotherapies; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Herpes labialis; Herpes simplex virus infections

Most Recent Events

  • 07 Dec 2022 No development reported - Phase-II for Herpes labialis (Prevention, Recurrent) in USA (Topical) prior to December 2022 (NCT03521479)
  • 14 Jun 2022 The University of Texas Health Science Center plans to initiate early phase I trial in Alopecia Areata (In adolescents) in June 2022 (Topical) (NCT05414266)
  • 28 Apr 2020 No recent reports of development identified for phase-I development in Herpes-simplex-virus-infections in USA (Topical, Liquid)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top